Skip to main content

9 Meters Biopharma, Inc.

NMTRDelisted Sep 8, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001551986

9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding 9 Meters Biopharma, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of NMTR: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders105104−1
Shares72.6M78.9M+6.29M (+8.7%)
Value$94.2M$76.8M−$17.5M (−18.6%)

New holders (13)

Institutions that held 9 Meters Biopharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to NMTR in Q4 2021
InstitutionSharesValue% of portfolio
Velan Capital Investment Management LP4,328,306$4.24M3.54%
Two Sigma Investments, LP316,480$310.0K0.00%
Adviser Investments LLC63,955$63.0K0.00%
Atom Investors LP39,605$39.0K0.01%
Keystone Wealth Services, LLC20,000$20.0K0.01%
StoneX Group Inc.20,000$19.6K0.00%
National Bank of Canada13,000$13.0K0.00%
HRT Financial LP13,283$13.0K0.00%
Sterling Investment Counsel, LLC12,533$12.0K0.01%
Tocqueville Asset Management L.P.10,200$10.0K0.00%
CoreCap Advisors, LLC6,010$6.00K0.00%
PSI Advisors, LLC2,000$2.00K0.00%
Northwestern Mutual Wealth Management Co25$00.00%

Sold out (14)

Institutions that held 9 Meters Biopharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.